Short Course of Bortezomib in Anemic Patients With Refractory Cold Agglutinin Disease
Clinical trial NCT01696474 · COMPLETED
Trial details
- NCT number
- NCT01696474
- Sponsor
- Gruppo Italiano Malattie EMatologiche dell'Adulto
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-01
- Primary completion
- 2017-03-27
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.